• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板输注无效的定义。

The definition of refractoriness to platelet transfusions.

作者信息

Bishop J F, Matthews J P, Yuen K, McGrath K, Wolf M M, Szer J

机构信息

Peter MacCallum Cancer Institute, Alfred Hospital, Melbourne, Australia.

出版信息

Transfus Med. 1992 Mar;2(1):35-41. doi: 10.1111/j.1365-3148.1992.tb00132.x.

DOI:10.1111/j.1365-3148.1992.tb00132.x
PMID:1308461
Abstract

The relationship between the 1 and 20 h post-transfusion platelet count and three parameters used to define refractory transfusions, namely the corrected increment (CI), platelet increment (PI), and percentage platelet recovery (%REC), was studied in 437 non-HLA matched platelet transfusions given to 102 patients with bone marrow failure. The percentage agreement between common definitions of refractoriness was calculated based on these parameters. As the maintenance of platelet counts above 20 x 10(9)/l is a relevant clinical goal for platelet support, the values of the CI, PI and %REC, which best corresponded to 1- and 20-h post-transfusion counts of 20 x 10(9)/l, were identified. A 1-h post-transfusion CI < 3 (PI < 7 x 10(9)/l or % REC < 8%) corresponded to clinically unsuccessful transfusions with a 1-h platelet count < 20 x 10(9)/l. A 1-h CI > or = 5.5 (PI > or = 12 x 10(9)/l or %REC > or = 14%) corresponded to clinically successful transfusions with a 20-h post-transfusion count of > or = 20 x 10/l. These data tie together the end points reported in the literature for defining refractory transfusions.

摘要

对102例骨髓衰竭患者进行了437次非HLA配型的血小板输注,研究了输血后1小时和20小时的血小板计数与用于定义难治性输血的三个参数之间的关系,这三个参数分别是校正增加值(CI)、血小板增加值(PI)和血小板回收率(%REC)。基于这些参数计算了难治性常见定义之间的百分比一致性。由于将血小板计数维持在20×10⁹/L以上是血小板支持的一个相关临床目标,因此确定了最符合输血后1小时和20小时血小板计数为20×10⁹/L的CI、PI和%REC值。输血后1小时CI<3(PI<7×10⁹/L或%REC<8%)对应于临床输血失败,即输血后1小时血小板计数<20×10⁹/L。输血后1小时CI≥5.5(PI≥12×10⁹/L或%REC≥14%)对应于临床输血成功,即输血后20小时血小板计数≥20×10⁹/L。这些数据将文献中报道的定义难治性输血的终点联系在一起。

相似文献

1
The definition of refractoriness to platelet transfusions.血小板输注无效的定义。
Transfus Med. 1992 Mar;2(1):35-41. doi: 10.1111/j.1365-3148.1992.tb00132.x.
2
Clinical perspectives of platelet transfusions: defining the optimal dose.血小板输注的临床观点:确定最佳剂量
J Clin Apher. 1995;10(3):124-7. doi: 10.1002/jca.2920100305.
3
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
4
The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.血小板难治性骨髓移植患者:出血的预防与治疗
Semin Oncol. 1993 Oct;20(5 Suppl 6):102-9.
5
Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.人类白细胞抗原同种免疫与同种免疫性血小板输注无效
Transfus Med Rev. 2020 Oct;34(4):250-257. doi: 10.1016/j.tmrv.2020.09.010. Epub 2020 Oct 7.
6
Complement as an Immune Barrier in Platelet Transfusion Refractoriness.补体作为血小板输注无效的免疫屏障。
Transfus Med Rev. 2019 Oct;33(4):231-235. doi: 10.1016/j.tmrv.2019.09.003. Epub 2019 Oct 18.
7
The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.供者血小板功能变化对输血结局的影响:一项半随机对照试验。
Blood. 2017 Jul 13;130(2):214-220. doi: 10.1182/blood-2017-01-759258. Epub 2017 May 9.
8
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
9
Platelet transfusion refractoriness.血小板输注无效
Br J Haematol. 2008 Jul;142(3):348-60. doi: 10.1111/j.1365-2141.2008.07189.x. Epub 2008 May 28.
10
Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.重症监护病房中的血小板输注实践:来自大型输血登记处的数据。
Chest. 2016 Sep;150(3):516-23. doi: 10.1016/j.chest.2016.04.004. Epub 2016 Apr 19.

引用本文的文献

1
Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis.2004年至2021年血小板输注无效的现状及全球趋势:一项文献计量分析
Front Med (Lausanne). 2022 May 6;9:873500. doi: 10.3389/fmed.2022.873500. eCollection 2022.
2
Platelet transfusion refractoriness: how do I diagnose and manage?血小板输注无效:如何诊断和处理?
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):527-532. doi: 10.1182/hematology.2020000137.
3
Applicability of an instrument to identify human leukocyte antigen-compatible donors for platelet transfusions.
一种用于识别血小板输注中人类白细胞抗原相容性供体的仪器的适用性。
Hematol Transfus Cell Ther. 2018 Oct-Dec;40(4):298-304. doi: 10.1016/j.htct.2018.03.004. Epub 2018 May 22.
4
Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.用血小板添加剂溶液洗涤制备富含血小板的白细胞浓缩物的质量评估和输血效果。
Blood Transfus. 2018 May;16(3):273-278. doi: 10.2450/2017.0277-16. Epub 2017 Apr 13.